These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23246968)

  • 41. Effect of mesoporous silica nanoparticles co‑loading with 17‑AAG and Torin2 on anaplastic thyroid carcinoma by targeting VEGFR2.
    Wang C; Zhang R; Tan J; Meng Z; Zhang Y; Li N; Wang H; Chang J; Wang R
    Oncol Rep; 2020 May; 43(5):1491-1502. PubMed ID: 32323855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints.
    Saleiro D; Platanias LC
    Semin Immunol; 2019 Jun; 43():101299. PubMed ID: 31771762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TOR as a Regulatory Target in
    Waltero C; de Abreu LA; Alonso T; Nunes-da-Fonseca R; da Silva Vaz I; Logullo C
    Front Physiol; 2019; 10():965. PubMed ID: 31417424
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer.
    Kumar J; Murugaiah V; Sotiriadis G; Kaur A; Jeyaneethi J; Sturniolo I; Alhamlan FS; Chatterjee J; Hall M; Kishore U; Karteris E
    Front Oncol; 2019; 9():542. PubMed ID: 31338320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics.
    Ghoneum A; Said N
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31284467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β
    Selvarajah B; Azuelos I; Platé M; Guillotin D; Forty EJ; Contento G; Woodcock HV; Redding M; Taylor A; Brunori G; Durrenberger PF; Ronzoni R; Blanchard AD; Mercer PF; Anastasiou D; Chambers RC
    Sci Signal; 2019 May; 12(582):. PubMed ID: 31113850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibroblast mTOR/PPARγ/HGF axis protects against tubular cell death and acute kidney injury.
    Gui Y; Lu Q; Gu M; Wang M; Liang Y; Zhu X; Xue X; Sun X; He W; Yang J; Zhao AZ; Xiao B; Dai C
    Cell Death Differ; 2019 Dec; 26(12):2774-2789. PubMed ID: 31024074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Global gene expression of histologically normal primary skin cells from BCNS subjects reveals "single-hit" effects that are influenced by rapamycin.
    Phatak A; Athar M; Crowell JA; Leffel D; Herbert BS; Bale AE; Kopelovich L
    Oncotarget; 2019 Feb; 10(14):1360-1387. PubMed ID: 30858923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and targeting of novel CDK9 complexes in acute myeloid leukemia.
    Beauchamp EM; Abedin SM; Radecki SG; Fischietti M; Arslan AD; Blyth GT; Yang A; Lantz C; Nelson A; Goo YA; Akpan I; Eklund EA; Frankfurt O; Fish EN; Thomas PM; Altman JK; Platanias LC
    Blood; 2019 Mar; 133(11):1171-1185. PubMed ID: 30587525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological Aspects of mTOR in Leukemia.
    Mirabilii S; Ricciardi MR; Piedimonte M; Gianfelici V; Bianchi MP; Tafuri A
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30110936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor microenvironment mediated by suppression of autophagic flux drives liver malignancy.
    Chen KD; Lin CC; Tsai MC; Huang KT; Chiu KW
    Biomed J; 2018 Jun; 41(3):163-168. PubMed ID: 30080656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening and purification of natural products from actinomycetes that affect the cell shape of fission yeast.
    Lewis RA; Li J; Allenby NEE; Errington J; Hayles J; Nurse P
    J Cell Sci; 2017 Sep; 130(18):3173-3185. PubMed ID: 28775153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.
    Yeung Y; Lau DK; Chionh F; Tran H; Tse JWT; Weickhardt AJ; Nikfarjam M; Scott AM; Tebbutt NC; Mariadason JM
    Mol Oncol; 2017 Sep; 11(9):1130-1142. PubMed ID: 28544747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma.
    Dolezal JM; Wang H; Kulkarni S; Jackson L; Lu J; Ranganathan S; Goetzman ES; Bharathi SS; Beezhold K; Byersdorfer CA; Prochownik EV
    J Biol Chem; 2017 Jun; 292(24):10068-10086. PubMed ID: 28432125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central Regulatory Role for SIN1 in Interferon γ (IFNγ) Signaling and Generation of Biological Responses.
    Kroczynska B; Blyth GT; Rafidi RL; Majchrzak-Kita B; Xu L; Saleiro D; Kosciuczuk EM; Jemielity J; Su B; Altman JK; Eklund EA; Fish EN; Platanias LC
    J Biol Chem; 2017 Mar; 292(11):4743-4752. PubMed ID: 28174303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type Development.
    Gentile G; Ceccarelli M; Micheli L; Tirone F; Cavallaro S
    Front Pharmacol; 2016; 7():449. PubMed ID: 27965576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer.
    Gugnoni M; Sancisi V; Manzotti G; Gandolfi G; Ciarrocchi A
    Cell Death Dis; 2016 Dec; 7(12):e2520. PubMed ID: 27929542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells.
    Tang S; Tan G; Jiang X; Han P; Zhai B; Dong X; Qiao H; Jiang H; Sun X
    Oncotarget; 2016 Nov; 7(45):73257-73269. PubMed ID: 27689326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomes.
    Heger Z; Polanska H; Merlos Rodrigo MA; Guran R; Kulich P; Kopel P; Masarik M; Eckschlager T; Stiborova M; Kizek R; Adam V
    Sci Rep; 2016 Sep; 6():33379. PubMed ID: 27646588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection.
    Bedsaul JR; Zaritsky LA; Zoon KC
    J Interferon Cytokine Res; 2016 Nov; 36(11):652-665. PubMed ID: 27508859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.